Related Experiment Video
Updated: Jun 27, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and
1Department of Pharmaceutics, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Abstract:
Many studies have implicated nuclear factor E2-related factor 2 (Nrf2) and nuclear factor-kappaB1 (Nfkb1) in inflammation and cancer. However, the regulatory potential for crosstalk between these two important transcription factors in inflammation and carcinogenesis has not been explored. To delineate conserved transcription factor-binding site signatures, we performed bioinformatic analyses on the promoter regions of human and murine Nrf2 and Nfkb1. We performed multiple sequence alignment of Nrf2 and Nfkb1 genes in five mammalian species - human, chimpanzee, dog, mouse and rat - to explore conserved biological features. We constructed a canonical regulatory network for concerted modulation of Nrf2 and Nfkb1 involving several members of the mitogen-activated protein kinase (MAPK) family and present a putative model for concerted modulation of Nrf2 and Nfkb1 in inflammation/carcinogenesis. Our results reflect potential for putative crosstalk between Nrf2 and Nfkb1 modulated through the MAPK cascade that may influence inflammation-associated etiopathogenesis of cancer. Taken together, the elucidation of potential relationships between Nrf2 and Nfkb1 may help to better understand transcriptional regulation, as well as transcription factor networks, associated with the etiopathogenesis of inflammation and cancer.
Insights
This study explores the interaction between nuclear factor E2-related factor 2 (Nrf2) and nuclear factor-kappaB1 (Nfkb1) in cancer and inflammation. Findings suggest a crosstalk mechanism modulated by the MAPK cascade, impacting cancer development.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Nuclear factor E2-related factor 2 (Nrf2) and nuclear factor-kappaB1 (Nfkb1) are key transcription factors implicated in inflammation and cancer.
- The potential for regulatory crosstalk between Nrf2 and Nfkb1 in these processes remains largely unexplored.
Purpose of the Study:
- To investigate the conserved regulatory mechanisms and potential crosstalk between Nrf2 and Nfkb1.
- To delineate transcription factor-binding site signatures and construct a regulatory network.
Main Methods:
- Bioinformatic analyses of promoter regions of human and murine Nrf2 and Nfkb1.
- Multiple sequence alignment of Nrf2 and Nfkb1 genes across five mammalian species.
- Construction of a canonical regulatory network involving the mitogen-activated protein kinase (MAPK) family.
Main Results:
- Identified conserved transcription factor-binding site signatures.
- Developed a putative model for the concerted modulation of Nrf2 and Nfkb1 via the MAPK cascade.
- Demonstrated potential crosstalk between Nrf2 and Nfkb1 influencing inflammation-associated carcinogenesis.
Conclusions:
- The findings reveal a potential crosstalk between Nrf2 and Nfkb1, mediated by the MAPK cascade.
- Understanding these relationships enhances knowledge of transcriptional regulation in inflammation and cancer.
- This research provides insights into transcription factor networks relevant to cancer etiopathogenesis.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
